Filing Details
- Accession Number:
- 0001209191-17-049038
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-15 17:31:43
- Reporting Period:
- 2017-08-11
- Filing Date:
- 2017-08-15
- Accepted Time:
- 2017-08-15 17:31:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1001233 | Sangamo Therapeutics Inc | SGMO | Biological Products, (No Disgnostic Substances) (2836) | 680359556 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1691262 | Iii A. Curt Herberts | C/O Sangamo Therapeutics, Inc. Point Richmond Tech Ctr, 501 Canal Blvd. Richmond CA 94804 | Sr.vp & Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-08-11 | 3,474 | $3.99 | 23,991 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-08-11 | 3,000 | $2.55 | 26,991 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-08-11 | 6,474 | $10.00 | 20,517 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-08-14 | 5,000 | $5.12 | 25,517 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-08-14 | 5,000 | $11.00 | 20,517 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-08-11 | 3,474 | $0.00 | 3,474 | $3.99 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-08-11 | 3,000 | $0.00 | 3,000 | $2.55 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-08-14 | 5,000 | $0.00 | 5,000 | $5.12 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-10-17 | No | 4 | M | Direct | |
| 0 | 2021-12-27 | No | 4 | M | Direct | |
| 0 | 2021-08-31 | No | 4 | M | Direct |
Footnotes
- All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017.
- The shares underlying the stock option are fully vested and exercisable.
Billionaire Hedge Funds
